A collapsin response mediator protein 2 isoform controls myosin II-mediated cell migration and matrix assembly by trapping ROCK II

Molecular and Cellular Biology

Volumn 32, Issue 10, 2012, Pages 1788-1804

  Yoneda, Atsuko ^a,c   Morgan Fisher, Marie ^a   Wait, Robin ^b   Couchman, John R ^a   Wewer, Ulla M ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; FIBRONECTIN; MYOSIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL FUNCTION; CELL MIGRATION; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; EPITHELIUM CELL; EXTRACELLULAR MATRIX; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; UBIQUITINATION;

ANIMALS; CELL LINE; CELL MOVEMENT; EPITHELIUM; EXTRACELLULAR MATRIX; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MYOSIN TYPE II; NERVE TISSUE PROTEINS; NEURONS; ORGAN SPECIFICITY; PROTEIN ISOFORMS; RATS; RHO-ASSOCIATED KINASES; RNA SPLICING;

EID: 84861412659     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06235-11     Document Type: Article

References (67)

1. Amano M, et al. 1997. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 275:1308-1311.
2. Amano M, et al. 1999. The COOH terminus of Rho-kinase negatively regulates rho-kinase activity. J. Biol. Chem. 274:32418-32424.
3. Amano M, Nakayama M, Kaibuchi K. 2010. Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken) 67:545-554.
4. Arimura N, et al. 2000. Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse. J. Biol. Chem. 275:23973-23980.
5. Arimura N, Menager C, Fukata Y, Kaibuchi K. 2004. Role of CRMP-2 in neuronal polarity. J. Neurobiol. 58:34-47.
6. Barkan D, Green JE, Chambers AF. 2010. Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur. J. Cancer 46:1181-1188.
7. Brown M, et al. 2004. Alpha2-chimaerin, cyclin-dependent kinase 5/p35, and its target collapsin response mediator protein-2 are essential components in semaphorin 3A-induced growth-cone collapse. J. Neurosci. 24: 8994-9004.
8. Burridge K, Wennerberg K. 2004. Rho and Rac take center stage. Cell 116:167-179.
9. Campellone KG, Welch MD. 2010. A nucleator arms race: cellular control of actin assembly. Nat. Rev. Mol. Cell Biol. 11:237-251.
10. Chen XQ, et al. 2002. Characterization of RhoA-binding kinase ROKalpha implication of the pleckstrin homology domain in ROKalpha function using region-specific antibodies. J. Biol. Chem. 277:12680-12688.
11. Croft DR, et al. 2004. Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis. Cancer Res. 64:8994-9001.
12. Defilles C, et al. 2009. Alphavbeta5/beta6 integrin suppression leads to a stimulation of alpha2beta1 dependent cell migration resistant to PI3K/Akt inhibition. Exp. Cell Res. 315:1840-1849.
13. Deo RC, et al. 2004. Structural bases for CRMP function in plexindependent semaphorin3A signaling. EMBO J. 23:9-22.
14. Dovas A, et al. 2010. Serine 34 phosphorylation of rho guanine dissociation inhibitor (RhoGDIalpha) links signaling from conventional protein kinase C to RhoGTPase in cell adhesion. J. Biol. Chem. 285:23296-23308.
15. Gao X, et al. 2010. Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer. Oncogene 29:4555-4566.
16. Gong W, et al. 2009. P21-activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration. Int. J. Cancer 125:548-555.
17. Gu Y, Hamajima N, Ihara Y. 2000. Neurofibrillary tangle-associated collapsin response mediator protein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518, and Ser-522. Biochemistry 39:4267-4275.
18. Hahmann C, Schroeter T. 2010. Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity. Cell. Mol. Life Sci. 67:171-177.
19. Hamajima N, et al. 1996. A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. Gene 180:157-163.
20. Hedgecock EM, Culotti JG, Thomson JN, Perkins LA. 1985. Axonal guidance mutants of Caenorhabditis elegans identified by filling sensory neurons with fluorescein dyes. Dev. Biol. 111:158-170.
21. Hensley K, Venkova K, Christov A, Gunning W, Park J. 2011. Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications. Mol. Neurobiol. 43:180-191.
22. Ishizaki T, et al. 2000. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol. Pharmacol. 57:976-983.
23. Jacobs M, et al. 2006. The structure of dimeric ROCK I reveals the mechanism for ligand selectivity. J. Biol. Chem. 281:260-268.
24. Kamijo H, et al. 2011. Impaired vascular remodeling in the yolk sac of embryos deficient in ROCK-I and ROCK-II. Genes Cells 16:1012-1021.
25. Kawano Y, et al. 1999. Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J. Cell Biol. 147: 1023-1038.
26. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. 2002. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74:5383-5392.
27. Kumar R, Gururaj AE, Barnes CJ. 2006. p21-activated kinases in cancer. Nat. Rev. Cancer 6:459-471.
28. Lane J, Martin TA, Watkins G, Mansel RE, Jiang WG. 2008. The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int. J. Oncol. 33:585-593.
29. Lee DH, et al. 2009. Targeted disruption of ROCK1 causes insulin resistance in vivo. J. Biol. Chem. 284:11776-11780.
30. Lee HH, Chang ZF. 2008. Regulation of RhoA-dependent ROCKII activation by Shp2. J. Cell Biol. 181:999-1012.
31. Leibovitz A, et al. 1976. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 36:4562-4569.
32. Lochhead PA, Wickman G, Mezna M, Olson MF. 2010. Activating ROCK1 somatic mutations in human cancer. Oncogene 29:2591-2598.
33. Lydolph MC, et al. 2009. Alpha9beta1 integrin in melanoma cells can signal different adhesion states for migration and anchorage. Exp. Cell Res. 315:3312-3324.
34. McCarthy KJ, Bynum K, St John PL, Abrahamson DR, Couchman JR. 1993. Basement membrane proteoglycans in glomerular morphogenesis: chondroitin sulfate proteoglycan is temporally and spatially restricted during development. J. Histochem. Cytochem. 41:401-414.
35. McKeown-Longo PJ, Mosher DF. 1983. Binding of plasma fibronectin to cell layers of human skin fibroblasts. J. Cell Biol. 97:466-472.
36. Mills GB, Moolenaar WH. 2003. The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 3:582-591.
37. Narumiya S, Tanji M, Ishizaki T. 2009. Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 28:65-76.
38. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. 2003. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75: 4646-4658.
39. Niault T, et al. 2009. From autoinhibition to inhibition in trans: the Raf-1 regulatory domain inhibits Rok-alpha kinase activity. J. Cell Biol. 187: 335-342.
40. Parsons JT, Horwitz AR, Schwartz MA. 2010. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat. Rev. Mol. Cell Biol. 11: 633-643.
41. Pearce LR, Komander D, Alessi DR. 2010. The nuts and bolts of AGC protein kinases. Nat. Rev. Mol. Cell Biol. 11:9-22.
42. Pellegrin S, Mellor H. 2007. Actin stress fibres. J. Cell Sci. 120:3491-3499.
43. Ridley AJ, Hall A. 1992. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389-399.
44. Riento K, Ridley AJ. 2003. Rocks: multifunctional kinases in cell behaviour. Nat. Rev. Mol. Cell Biol. 4:446-456.
45. Rosslenbroich V, et al. 2005. Collapsin response mediator protein-4 regulates F-actin bundling. Exp. Cell Res. 310:434-444.
46. Sanz-Moreno V, et al. 2008. Rac activation and inactivation control plasticity of tumor cell movement. Cell 135:510-523.
47. Schmidt EF, Strittmatter SM. 2007. The CRMP family of proteins and their role in Sema3A signaling. Adv. Exp. Med. Biol. 600:1-11.
48. Sechler JL, Takada Y, Schwarzbauer JE. 1996. Altered rate of fibronectin matrix assembly by deletion of the first type III repeats. J. Cell Biol. 134: 573-583.
49. Shi J, Zhang L, Wei L. 2011. Rho-kinase in development and heart failure: insights from genetic models. Pediatr. Cardiol. 32:297-304.
50. Shih JY, et al. 2001. Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. J. Natl. Cancer Inst. 93:1392-1400.
51. Shimizu Y, et al. 2001. Contribution of small GTPase Rho and its target protein rock in a murine model of lung fibrosis. Am. J. Respir. Crit. Care Med. 163:210-217.
52. Singh P, Carraher C, Schwarzbauer JE. 2010. Assembly of fibronectin extracellular matrix. Annu. Rev. Cell Dev. Biol. 26:397-419.
53. Stenmark P, et al. 2007. The structure of human collapsin response mediator protein 2, a regulator of axonal growth. J. Neurochem. 101:906-917.
54. Tahimic CG, et al. 2006. Evidence for a role of collapsin response mediator protein-2 in signaling pathways that regulate the proliferation of nonneuronal cells. Biochem. Biophys. Res. Commun. 340:1244-1250.
55. Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. 2009. Nonmuscle myosin II takes centre stage in cell adhesion and migration. Nat. Rev. Mol. Cell Biol. 10:778-790.
56. Vincent P, et al. 2005. A role for the neuronal protein collapsin response mediator protein 2 in T lymphocyte polarization and migration. J. Immunol. 175:7650-7660.
57. Wait R, et al. 2002. Strategies for proteomics with incompletely characterized genomes: the proteome of Bos taurus serum. Electrophoresis 23: 3418-3427.
58. Wang LH, Strittmatter SM. 1997. Brain CRMP forms heterotetramers similar to liver dihydropyrimidinase. J. Neurochem. 69:2261-2269.
59. Ward Y, et al. 2002. The GTP binding proteins Gem and Rad are negative regulators of the Rho-Rho kinase pathway. J. Cell Biol. 157:291-302.
60. White ES, Baralle FE, Muro AF. 2008. New insights into form and function of fibronectin splice variants. J. Pathol. 216:1-14.
61. Wittig I, Braun HP, Schagger H. 2006. Blue native PAGE. Nat. Protoc. 1:418-428.
62. Wolfenson H, Henis YI, Geiger B, Bershadsky AD. 2009. The heel and toe of the cell's foot: a multifaceted approach for understanding the structure and dynamics of focal adhesions. Cell Motil. Cytoskeleton 66:1017-1029.
63. Wu CC, et al. 2008. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics 8:316-332.
64. Yamaguchi H, Kasa M, Amano M, Kaibuchi K, Hakoshima T. 2006. Molecular mechanism for the regulation of rho-kinase by dimerization and its inhibition by fasudil. Structure 14:589-600.
65. Yoneda A, Multhaupt HA, Couchman JR. 2005. The Rho kinases I and II regulate different aspects of myosin II activity. J. Cell Biol. 170:443-453.
66. Yoneda A, Ushakov D, Multhaupt HA, Couchman JR. 2007. Fibronectin matrix assembly requires distinct contributions from Rho kinases I and -II. Mol. Biol. Cell 18:66-75.
67. Yuasa-Kawada J, et al. 2003. Axonal morphogenesis controlled by antagonistic roles of two CRMP subtypes in microtubule organization. Eur. J. Neurosci. 17:2329-2343.